To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 1 March 2022 to Question 100420, on Coronavirus: Immune Thrombocytopenic Purpura, if he will publish the evidence relied upon in reaching the determination that an association between the AstraZeneca covid-19 vaccine and TTS was likely.
This answer is the replacement for a previous holding answer.
28 April 2022
It has not proved possible to respond to the hon. Member in the time available before Prorogation.